Hungarian experience with Langerhans cell histiocytosis in childhood

Pediatric Hematology and Oncology

Volumn 23, Issue 2, 2006, Pages 135-142

  Müller, Judit ^a   Garami, Miklós ^a   Hauser, Péter ^a   Schuler, Dezso ^a   Csóka, Monika ^a   Kovács, Gábor ^a   Renyi I ^b   Marosi, A ^c   Galantai I ^d   Bekesi A ^e   Kajtar P ^f   Kiss, Cs ^g   Nagy, K ^h   Bartyik, K ⁱ   Masath P ^j   Krivan G ^k  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c HEIM PÁL CHILDREN S HOSPITAL   (Hungary)

^d Madarasz Children's Hospital   (Hungary)

^e Bethesda Hospital   (Hungary)

^f UNIVERSITY OF PÉCS   (Hungary)

^g UNIVERSITY OF DEBRECEN   (Hungary)

^h Borsod County Teaching Hospital   (Hungary)

ⁱ UNIVERSITY OF SZEGED   (Hungary)

^j Markusovszky Teaching Hospital   (Hungary)

^k Szent Laszlo Hospital   (Hungary)

more..

Author keywords

Histiocytosis X; Langerhans cell histiocytosis; Pediatric oncology; Treatment results

Indexed keywords

STEROID;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CANCER REGISTRY; CHEMOTHERAPY; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HISTIOCYTOSIS; HUMAN; HUNGARY; INCIDENCE; INFANT; IRRADIATION; LANGERHANS CELL; LANGERHANS CELL HISTIOCYTOSIS; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RELAPSE; REMISSION; RISK FACTOR; SEX DIFFERENCE; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; HUNGARY; INCIDENCE; INFANT; MALE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 31644451447     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010500457988     Document Type: Article

References (24)

1. Chu T, D'Angio GJ, Favara BE, Ladisch S, Nesbit M, Pritchard J. Histiocytosis syndromes in children. Lancet. 1987;1:208-209.
2. Lichtenstein L. Histiocytosis X, integration of eosinophilic granuloma of bone, Letterer-Siwe disease and Schüller-Christian disease as related manifestations of a single nosologic entity. Arch Patol. 1953;56:84-102.
3. Langerhans P. Über die Nerven der menschlichen Haut. Virchows. Arch Abl B Pathol. 1868;44:325-337.
4. de Graaf JH, Egeler RM. New insights into the patogenesis of Langerhans cell histiocytosis. Curr Opin Pediatr. 1997;9:46-50.
5. Willman CL, Busque L, Griffith BB, et al. Langerhans'-cell histiocytosis (histiocytosis X) - a clonal proliferative disease. N Engl J Med. 1994;331:154-160.
6. Zelger B. Langerhans cell histiocytosis: a reactive or neoplastic disorder? Med Pediatr Oncol. 2001;7:543-544.
7. Favara BE, Feller AC, Pauli M, et al. Contemporary classification of histiocytosis disorders. Med Pediatr Oncol. 1997;39:157-166.
8. Nezelof C, Basset F. Langerhans cell histiocytosis research: past, present, and future. Hematol Oncol Clin North Am. 1998;12:385-406.
9. Kusumakumary P, James FV, Chellam VG, Ratheesan K, Nair MK. Disseminated Langerhans cell histocytosis in children: treatment outcome. Am J Clin Oncol. 1999;22:180-183.
10. Kilborn TN, The J, Goodman TR. Paediatric manifestations of Langerhans cell histiocytosis: a review of the clinical and radiological findings. Clin Radiol. 2003;58:269-278.
11. Howarth DM, Mullan BP, Wiseman GA, Wenger DE, Forstrom LA, Dunn WL. Bone scintigraphy evaluated in diagnosis and staging Langerhans' cell histiocytosis and related disorders. J Nucl Med. 1996;37:1456-1460.
12. Chu T. Langerhans cell histiocytosis. Australas J Dermatol. 2001;42:237-242.
13. Gadner H, Grois N, Arico M, et al. A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. J Pediatr. 2001;138:728-734.
14. Ladisch S. Langerhans histiocytosis. Curr Opin Hematol. 1998;5:54-58.
15. Titgemeyer C, Grois N, Minkov M, Flucher-Wolfram B, Gatterer-Menz I, Gadner H. Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-Study. Med Pediatr Oncol. 2001;37:108-114.
16. Nagarajan R, Neglia J, Ramsay N, Baker KS. Successful treatment of refractory Langerhans cell histiocytosis with unrelated cord blood transplantation. J Pediatr Hematol Oncol. 2001;23:629-632.
17. Suminoe A, Matsuzaki A, Hattori H, Ishii S, Hara T. Unrelated cord blood transplantation for an infant with chemotherapy-resistant progressive Langerhans cell histiocytosis. J Pediatr Hematol Oncol. 2001;23:633-636.
18. Zeller B, Storm-Mathisen I, Smevik B, Lie SO. Multisystem Langerhans-cell histiocytosis with life-threatening pulmonary involvement-good response to cyclosporine A. Med Pediatr Oncol. 2000;35:438-442.
19. Stine KC, Saylors RI, Wiliams LL, Becton DL. 2-Chlorodeoxyadenosine (2-CDA) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients. Med Pediatr Oncol. 1997;329:734-735.
20. Horwarth DM, Gilchrist GS, Mullan BP, Wiseman GA, Edmonson JH, Schomberg Pj. Langerhans cell histiocytosis. Cancer. 1999;85:2278-2290.
21. Lahey ME. Histicytosis X - an analysis of prognostic factors. J Pediatr. 1975;87:184-189.
22. Minkov M, Grois N, Heitger A, Potschger U, Westermeier T, Gadner H, DAL-HX Study Group. Response to initial treatment of multisystem Langerhans cell histiocytosis: an important prognostic indicator. Med Pediatr Oncol. 2002;39:581-585.
23. Broadbent V, Gadner H, Komp DM, Ladisch S. Histiocytosis syndromes in children, II: approach to the clinical and laboratory evaluation of children with Langerhans cell histiocytosis. Med Pediatr Oncol. 1989;17:492-495.
24. Egeler RM, D'Angio GJ. Langerhans cell histiocytosis. J Pediatr 1995;127:1-11.